Viewing Study NCT02647632


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2026-02-20 @ 7:24 PM
Study NCT ID: NCT02647632
Status: COMPLETED
Last Update Posted: 2017-06-29
First Post: 2015-12-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir
Sponsor: ANRS, Emerging Infectious Diseases
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HCV genotype 1 or 4 View
None failure to DAA View